Global Womens Health Diagnostics Market 2025–2034

Women’s Health Diagnostics Market: Overview

The area of medicine known as women’s health is primarily concerned with the treatment and diagnosis of illnesses and ailments that have an impact on a woman’s health. Breast cancer, ovarian cancer, cervical cancer, menopause, and pregnancy are just a few of the women’s health diseases that may be detected through screening, testing, diagnosis, and monitoring.

There are several test kinds available to diagnose illnesses affecting women’s health. Medical diagnostic tools including biopsy machines, imaging and monitoring systems, mammography machines, and others aid with illness screening and diagnosis by detecting cancer, clearing obstructions, and taking pictures of inside organs. The worldwide demand for numerous health diagnostic tests has grown dramatically.

The market is now primarily driven by rising chronic and lifestyle disorders, increasing chronic illness awareness, and the high prevalence of infectious diseases including HIV and hepatitis in women throughout the world. During the projected period, this market’s expansion is anticipated to be aided by rising POC diagnostic testing adoption rates as well as an increase in the number of diagnostic and imaging facilities.

Women’s Health Diagnostics Market: COVID–19 Impact Analysis

Global economies have been significantly impacted by the COVID-19 pandemic. For several industries, COVID-19 has created a number of difficulties. International trade and travel have been hampered as more and more nations across the world have restricted travel and closed their borders in an effort to curb the coronavirus (COVID-19) epidemic since the year 2020 began.

Due to the disruption of the supply chains for the market for women’s health diagnostics, there was a temporary decline in demand as a result of the unpredictability of the global economy and capital markets. Unfavourable changes in policies and laws are hindering the expansion of this industry during the COVID-19 epidemic. The risk of COVID-19 infection is higher for breast cancer patients than for healthy persons, according to major regulatory agencies.

As a result, screening, operations, and diagnostic tests are delayed and severely constrained in hospitals and breast cancer treatment facilities. The market for diagnostics for women’s health is growing despite the low screening rates brought on by COVID-19. The delay in the detection of breast cancer also affected its treatment, which is anticipated to cause market disruption in the breast cancer treatment and diagnosis sectors.

Women’s Health Diagnostics Market: Growth Drivers

An increasing number of elderly people accelerates the market’s growth

The increase in the geriatric population promotes market growth since older individuals have diminished physiological capabilities, poorer blood circulation, and are more susceptible to chronic illnesses. Age-related sexual issues are prevalent among women.

The necessity for diagnostics for women’s health has increased along with the number of patients. Since menopause can increase the risk of developing certain medical conditions including cardiovascular disease and urinary incontinence, a significant increase in the number of women over 50 is driving the market.

Demand for efficient women’s health diagnostics is increased by infections in pregnant women.

Concerns about the accurate detection of different illnesses have been raised due to the high dangers connected with the transfer of infectious diseases to pregnant women. In order to enhance patient outcomes, top companies in the market for women’s health diagnostics are enhancing the efficacy of their laboratory testing solutions.

For instance, TORCH (toxoplasmosis, other (e.g., syphilis, HIV), rubella, cytomegalovirus (CMV), and herpes simplex virus) infections, malnutrition, and bone diseases are just a few of the laboratory testing options Siemens Healthineers, a leading global provider of medical technology, offers for women. Healthcare organizations in the women’s health diagnostics market are seizing possibilities in infectious disease testing and diagnostic laboratory testing, both of which are predicted to see strong growth over the forecast period.

The need for effective treatment options in women’s health diagnostics is being fueled by the rising occurrence of infections that result in miscarriage and birth abnormalities in newborns.

Women’s Health Diagnostics Market: Segmentation Analysis

The women’s health diagnostics market is segmented into application and end use. Based on application, the market for cancer testing segment is estimated to lead the market during the forecast period. Due to the development of highly accurate, technologically advanced hybrid imaging tools, cancer testing dominated the market in 2021. The market is expected to increase as a result of numerous partnerships between major firms, governments, and other organizations. These partnerships aim to improve patients’ access to diagnostics for a range of disorders.

By end use, the hospitals and diagnostics centers segment is anticipated to dominate the market during the forecast period. In 2021, the sector of hospitals and diagnostics centers contributed the most to the market. Hospitalizations have increased significantly as a result of the growth in breast and ovarian cancer incidence. Since they are frequently the first choice for patients for the detection of cancer, infectious diseases, and osteoporosis, among other things, the industry is anticipated to continue its market position through 2030.

Throughout the anticipated period, the home category is anticipated to grow quickly as market participants expand their investments in the commercialization of portable and point-of-care devices. Additionally, increased consumer awareness of home diagnostic tools is anticipated to fuel business expansion.

Report Scope

Key Insights:

• Based on application segmentation, the cancer testing segment is estimated to hold the largest market share during the forecast period.
• Based on end use segmentation, the hospital and diagnostics centers segment in the women’s health diagnostics market is the leading revenue-generating category during the forecast period.
• On the basis of geography/region, the North America region was the leading revenue generator in 2021.

Recent Development

• February 2021: SmartBreast has purchased the molecular breast imaging assets from GE Healthcare for an unknown sum. As part of the agreement, the business obtained the designs for MBI scanners, the Discovery NM750B, as well as several other production tools and associated patents.
• November 2020: A partnership between RadNet and Hologic Inc. has been announced in an effort to accelerate the creation of artificial intelligence solutions for breast health. Research and development, data exchange, and an update to Radnet’s fleet of Hologic mammography systems are all goals of the cooperation.

Regional Landscape

Throughout the projection period, North America is expected to continue to be among the most alluring markets and this region is accounted for the majority revenue share in the market.

The substantial market share of this sector may be due to the rising incidence of cancer in women, the growing emphasis on establishing a presence in this area among producers of diagnostic devices for women’s health, and the rising demand for fertility testing monitors. During the projected period, it is also anticipated that the growing popularity of POC diagnostics and PST procedures would fuel the expansion of this regional market.

Due to the region’s expanding healthcare infrastructure, considerable growth in the market for women’s health diagnostics is also anticipated. Additionally, the government’s programs include a rise in women’s employment involvement. Additionally, it is projected that in the upcoming years, increased awareness of women’s health diseases would fuel the expansion of the region’s market for women’s health diagnostics.

Competitive Landscape

Our report offers both quantitative and qualitative insights into the WebRTC market and major development initiatives adopted by the key players. Further, it offers competitive details and market share analysis. The report further includes relevant financial information, products and services offered, SWOT analysis, and recent developments of the players profiled.

List of the prominent players in the global women’s health diagnostics market:

• Siemens
• Carestream Health
• MEDGYN PRODUCTS INC.
• URIT MEDICAL ELECTRONIC CO. LTD
• COOK
• Cardinal Health
• NeuroLogica Corp.
• Shimadzu Corporation
• PerkinElmer Inc.
• General Electric Company
• Hologic Inc.
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• Abbott
• BD
• Danaher
• Sysmex Corporation
• Hitachi Ltd.
• Others

The global Women’s health diagnostics market is segmented as follows:

By Application

• Cancer
• Infectious Disease Testing
• Osteoporosis Testing
• Pregnancy and Fertility Testing
• Prenatal Testing

By End Use

• Hospital and Diagnostics Centers
• Home

By Region

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America